chrisvoncsefalvay/vaers-outcomes huggingface dataset:
big, itchy rash at the injection site; very large lymph node on their neck.; their neck hurt a little; Little arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little arm soreness), NECK PAIN (their neck hurt a little), VACCINATION SITE RASH (big, itchy rash at the injection site) and LYMPHADENOPATHY (very large lymph node on their neck.) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included BISACODYL (LAXATIN), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and VITAMINS NOS for an unknown indication.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (Little arm soreness). On 07-Feb-2021, the patient experienced NECK PAIN (their neck hurt a little). On 08-Feb-2021, the patient experienced VACCINATION SITE RASH (big, itchy rash at the injection site) and LYMPHADENOPATHY (very large lymph node on their neck.). At the time of the report, PAIN IN EXTREMITY (Little arm soreness), NECK PAIN (their neck hurt a little), VACCINATION SITE RASH (big, itchy rash at the injection site) and LYMPHADENOPATHY (very large lymph node on their neck.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter.
pt recv vax 4NOV97 & 9NOV(7 pt devel herpes zoster;pt presented w/a vesicular rash (>200 lesions) on lt chest, midline back to midline chest, approx distributed along dermatome T8;PCR analysis positive for wild type varicella zoster virus;
She got the vaccine which was fine, at the end of the 20 minute waiting period had a spot the size of a dime, really sore and pink.  On her way home she started having bowel issues, got home and an hour to hour and half later got explosive diarrhea, which lasted 24 hours.  The spot on her arm got larger, more tender and felt warm to touch.  It got to be the size of a half softball size, no swelling.  Then she started having trouble breathing, could not walk as far or fast without breathing problems.  She then took it easy, and the breathing issues got worse for 36 hours.  On Sunday her arm was better, less sore and the diarrhea had stopped.  She then stopped improving and on Tuesday 2/16/21, she was told to go to the minute clinic on 2/18/21 and when she got there her pulse rate was 40, her oxygen level was 93, and her BP was elevated.  The NP there she got her oxygen level up to 94, was real raspy in her lungs.  She was sent to the UC and they sent her to the ER.   She was seen in the ER and isolated her, did an EKG, had a chest x-ray, gave her breathing treatments, and waited on her results, which all came back fine.  They gave her 150 mg of Prednisone, another breathing treatment and within 1 1/2 hours her oxygen level was up to 97 and all of her tests were negative and they sent her home.  She has now been home since last Thursday with nebulizer treatments Ipratropium bromide and Albuteral sulfate 3 times a day, rescue inhaler 4 puffs every 6 hours, Advair twice a day as well.   She does have a FU with her doctor tomorrow for recheck.    She feels that she is almost back to normal.
I exp. fever, nausea, chills which lasted 24 hours. The red arm lasted for about 72 hours.
Child woke up to a painful, red, swollen and hot to touch left hand after receiving MCV4 and Tdap in the left deltoid area the day before. No swelling or discloration noted by mother at the injection site. Mother unable to identify any visable wounds or insect bites on the child's left hand. Child denied feeling ill except for left hand. Mother has been giving her child oil of oregano tabs to treat his left hand symptoms. The swelling, redness, pain and hot to touch is resolving.
Knot under skin at site of injection - (patient remained on premises for 20 min.)  Called patient @ 1:15 PM & she said her arm was fine and knot had gone away.
After this 2nd dose of the vaccine, I was awake during the night with fever, severe chills, frequent urination and achiness.  I also had a sore arm and fatigue for a few days.  It was shortly after the vaccine that I began to notice a ringing in my ears.  At first I didn't tie it back to the vaccine, but then I realized that I had never before had this and wondered if it could potentially be related.  I have since that time had two booster vaccines (also Moderna).  The ear ringing continues.  It is intermittent and more noticeable at night.  There are nights where it awakens me during the night and interferes with a good night sleep.  Again this is intermittent.  I notice it more often now and I just had my second booster on 4/15/22 so I thought I should report this in case the 2nd booster caused a flare up.
Running a Fever; Cough; sore throat; Little Congested; Sinus issues; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (Running a Fever), COUGH (Cough), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Little Congested) and SINUSITIS (Sinus issues) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: TETANUS ADS IMPFSTOFF (Routine Tetanus shot due to stepping on a nail 10 years ago. Scheduled on 15-APR-2021. Advised to Wait for additional 14 days to take vaccination) since an unknown date.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Running a Fever), COUGH (Cough), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Little Congested) and SINUSITIS (Sinus issues). At the time of the report, PYREXIA (Running a Fever), COUGH (Cough), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Little Congested) and SINUSITIS (Sinus issues) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
diagnosed with shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (diagnosed with shingles) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Alzheimer's disease.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced HERPES ZOSTER (diagnosed with shingles). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at an unspecified dose and frequency and ACICLOVIR (ZOVIRAX [ACICLOVIR]) at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (diagnosed with shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included pain medicine.  No concomitant medication was provided.
"urinated in PJs"; did not have strength to get back up; slept very sound; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 31-Mar-2021 and was forwarded to Moderna on 31-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (slept very sound), URINARY INCONTINENCE ("urinated in PJs") and ASTHENIA (did not have strength to get back up) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 002A21A) for COVID-19 vaccination.     The patient's past medical history included Hypertension (Controlled) since an unknown date, Sciatica, Arthritis and Cholesterol (Controlled). Concomitant products included GABAPENTIN, ATORVASTATIN, lanosterol, MELOXICAM, eye vitamin, AMLODIPINE and LOSARTAN for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 05-Mar-2021, the patient experienced SLEEP DISORDER (slept very sound). On 06-Mar-2021, the patient experienced ASTHENIA (did not have strength to get back up). On an unknown date, the patient experienced URINARY INCONTINENCE ("urinated in PJs"). At the time of the report, SLEEP DISORDER (slept very sound), URINARY INCONTINENCE ("urinated in PJs") and ASTHENIA (did not have strength to get back up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient was observed, to tilt head back like going to pass out, then slumped forward in chair, extremities convulsed and patient came to.   She reported feeling dizziness, chills, nausea and tingling in both hands.  I asked her if would like us to call EMS but refused medical attention.  She knew date and location when asked.  We offered to have family member pick her up but refused.
Chills, malaise, tiredness, stomach ache for three days.  Mornings were more symptom free than afternoons and evenings.
Vaccine was administered 1 hour past the expiration time. Vial was reconstituted at 9:13am on 12/6/2021 and expiration time was set as 3:13pm. Vaccine was administered to patient at 4:30pm.
Case number PHEH2015US022364, is an initial spontaneous report received from nurse on 29 Oct 2015. This report refers to a 53 year old female patient. Historical condition and concomitant medication were unknown. The patient was vaccinated with FLUVIRIN (batch number: 1515101) at a dose of 0.5ml subcutaneously on 21 Oct 2015. On the same day after vaccination patient had an injection site reaction. Outcome of the events was reported as unknown. Events were reported to be non-serious and causality of the events was not reported.
Severe pain in left arm around where shot was given, and also same pain started in left hip on the hip bone. It started about a week after shot and pain got progressively worse and peaked at four weeks after flu vaccine was given. Called pharmacist where shot was given. She said my nerves had been effected by vaccine and that I should ice it and take pain medication. Also, called my doctor's office and spoke with his nurse. She said she would talk with the doctor and call me back. She never did. That treatment helped and got a little better, but here I am 8 months later and I still have constant pain in my left arm and hip. Similar reaction the year before with the flu vaccine, but it was just my arm and it took about 6 months to get better. This last time has been much worse. I never had a problem with the flu vaccine until the H1N1 was added to it. In researching this I believe I have Guillain-Barre Syndrome. I plan to go to a different doctor to confirm this and try to seek treatment.
Immediately after receiving his 4th shot, Gardasil 9, patient went unconscious, closed his eyes and began to drift backward.  He went limp and began to slide off the table.  His father and I held him and he began to shake.  We placed him in a chair.  After 30 seconds, he regained consciousness and asked what happened.  He then turned white and vomited on the floor.  He continued to have nausea and lightheadedness for 10 minutes until he recovered.   The order of vaccine administration was Menactra first, Fluzone second, both in right arm, then Adacel third and Gardasil last, in left arm.  He was fine after the first 3 shots.
PATIENTS DAUGHTER WANTED NOTED PATIENTS MEMORY LOSS OCCURRED 3 WEEKS AFTER COVID SHOT
nose being plugged; runny nose; sinus infection; This spontaneous case was reported by a patient and describes the occurrence of NASAL CONGESTION (nose being plugged), RHINORRHOEA (runny nose) and SINUSITIS (sinus infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. In March 2021, the patient experienced NASAL CONGESTION (nose being plugged), RHINORRHOEA (runny nose) and SINUSITIS (sinus infection). At the time of the report, NASAL CONGESTION (nose being plugged), RHINORRHOEA (runny nose) and SINUSITIS (sinus infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details reported : amoxicillin   Reporter did not allow further contact
Lt leg with 3 separate erythema rash - raised - (1) -> 10cm x 12cm (Lt buttocks) (2) -> 10 cm x 20 cm (vastus lateralis) (3) 15 cm x 30 cm (vastus lateralis).
1-21-21.  Got first COIVID-19 vaccination at 7:15 AM (Phizer).  No reaction whatsoever.  Pfizer Lot:EL3249  2-11-21.  Got second vaccination at 7:05 AM.  Felt normal all day.  Pfizer Lot:EL9264   2-12-21.  Felt good early.  Played tennis and worked out.  About 2 PM, started feeling very poorly.  Took 90 minute nap.  Woke up nauseous and dizzy. Threw up several times.  Could not drink or eat dinner. 2-13-21,  Continued to feel badly.  Threw up after arising.  Couild not drink or eat breakfast.  About 1:30 PM, was able to keep yogurt and cottage cheese down.  Nibbled off and on. Ate light supper. 2-14-21.  Woke up dizzy.  Was able to eat normally.  Still felt badly.  Had bad headache (very unusual for me) before supper.  Ate normal supper.  Canceled tennis for following week. 2-15-21.  Started feeling much better than day before. 2-16-21.  Felt much better than the day before. 2-17-21.  Best day since 2-11 ? the last 5 days.   2-18-21.  Began to feel rocky.  Slightly dizzy.   Low energy 2-19-21.  Felt worse than the day before.  Low energy, short dizzy spells, little appetite. 2-20-21.  Felt really bad.  Very dizzy all day.  Drippy nose for 5 hours, but nose okay by bedtime.  Very tired all day.   2-21-21.  Felt a little better.  Still dizzy when I got up.  Recovered enough to go to church at 10 AM.  Note that it had been 10 days (at 7:05 AM) since I had my second shot. 2-22-21.  Got up to the bathroom at 2 AM.  Was dizzy.  Got back to sleep until 6:30 AM. Was and am better than the last 4-5 days.  Still feel a little shaky if I move quickly or get up out of my chair quickly.  Very tired all day.   2-23-21,  Doing better.  Still wobbly on my feet.  Only mildly dizzy.   2-24-21.  Best day since 2-17.  Still a little weak.  Worked out in the late AM.   2-25-21.  Felt a little dizzy in the AM.  Better after lunch.  Did light workout.  Good day overall.  Felt fine. 2-26-21.  Felt good in the AM.  Worked out.  Feeling stronger than yesterday even.   2-27-21.  Felt good 2-28-21.  Felt tired all day 3-1-21.  Did not sleep well.  Worked out in the AM and then was very tired.  Felt a little dizzy after returning home from the gym.  Took short nap before lunch and am doing better in the PM.
pt devel pallor & lethargy, followed by brief cyanotic & tremor about 1hr p/vax;shortly devel fever to 39.4 R;pt alert & responsive w/pallor, 45 min later;hosp for neuro eval;
SEE ADR NARRATIVIE Narrative: IMMEDIATE MOUTH TINGLING; DIPHENHYDRAMINE 25 MG PO LIQUID WAS GIVEN FROM EMERGENT  MEDS PACK
Patient reported chest pain and difficulty breathing and presented to the ED. He was given Benedryl and morphine and was fine four hours later. He did follow up with his PCP.
Covid booster  (3rd shot) given 18 days too soon. No adverse reaction. Parent notified
Patient reported excessive soreness and swelling in right arm that lasted over 3 weeks in duration, requring a trip to the doctor to get a steroid pain reliever on 10/25.
Information has been received from a health care worker and follow up information from a physician concerning a 23 year old Philippine male college student with no illness at the time of vaccination, no allergies and no past medical history reported who in December 2003 (also reported as 12/03/04), was vaccinated intramuscular with a second dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. It was reported that the first dose was given on 17NOV1992. On 03FEB2004 it was reported by the health care worker that the student now had the mumps. It was noted that laboratory evaluation revealed amylase was 7,000. They physician reported that the patient had parotitis. On 30JAN2004 at 10PM the patient developed bilateral swollen parotid glands. It was reported on 30JAN2004 by the physician that the impression was bilateral parotitis, hypercholesterolemia. It was noted that the patient awoke in the AM of 30JAN2004 with markedly swollen parotid glands. His oropharynx was unremarkable and he did not have difficulty swallowing. There were no other nodes palpable anywhere else. He had not had any dental work for several years. The physician noted there was the possibility of staphylococcal parotitis or Micholette syndrome. The patient was to be monitored for possible lymphoma although the physician noted that this appeared to be an acute process. The patient was started on antibiotic therapy cephalexin 500mg three times per day. Laboratory evaluation on 30JAN2004 revealed white blood cell count 11.6x10-3/ul, red blood cell count 5.80x 10-6/ul, AST 62IU/L and ALT 132 IU/L, IgG mumps antibody 2.20, amylase 7210 U/1, creatinine kinase 384 U/L and aldolase 11.3 U/L. On 02FEB2004 the patient was seen and the impression noted was acute mumps. The patient's parotid glands had decreased in size and he felt much better. He was able to chew comfortably. his mumps IgG was positive and his amylase was markedly elevated, although he had no scrotal discomfort or abdominal pain. He was eating. Laboratory evaluation on 06FEB2004 revealed amylase 160U/L. On 09FEB2004 the patient was seen and the impression reported was acute mumps resolving. The parotid swelling had resolved. His amylase had nearly returned to normal and no further follow up was necessary. The physician noted that apparently the patient had a mild acute case of mumps secondary to the recent vaccination. The reporter noted on the follow up information that on 09FEB2004 the patient had recovered from bilateral swollen parotid glands. Additional information has been requested.
my skin feels warm; I have a runny nose; I have joint pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (my skin feels warm), RHINORRHOEA (I have a runny nose), ARTHRALGIA (I have joint pain) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0165212A, 003B21A and 040A20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Augmentin), Acid reflux (esophageal) and Hernia (Patient had a hernia between her esophagus and top of her stomach.). Concomitant products included POTASSIUM CHLORIDE and PANTOPRAZOLE for an unknown indication.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 17-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2022, the patient experienced SKIN WARM (my skin feels warm), RHINORRHOEA (I have a runny nose), ARTHRALGIA (I have joint pain) and NAUSEA (Nausea). At the time of the report, SKIN WARM (my skin feels warm), RHINORRHOEA (I have a runny nose), ARTHRALGIA (I have joint pain) and NAUSEA (Nausea) had not resolved.            No treatment details were provided   This case was linked to MOD-2022-489275 (Patient Link).
Swollen leg at injection site, 24 hrs. after. Dr advised pts mother to give BENADRYL 3/4 tsp q6hrs. and cool compresses. Pt doing well and no symptoms next day.
Itching; Little bit nervous; This is a spontaneous report from a contactable consumer reporting for himself. A 59-year-old male patient received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced itching and little bit nervous on an unspecified date with outcome of unknown.    The information on the Lot/Batch number has been requested.
no adverse event; HCP called in to report that 16 patients was given the Moderna pediatric dose instead of the bivalent booster dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (HCP called in to report that 16 patients was given the Moderna pediatric dose instead of the bivalent booster dose.) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018C22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Jan-2023, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2023, the patient experienced WRONG PRODUCT ADMINISTERED (HCP called in to report that 16 patients was given the Moderna pediatric dose instead of the bivalent booster dose.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (HCP called in to report that 16 patients was given the Moderna pediatric dose instead of the bivalent booster dose.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (HCP called in to report that 16 patients was given the Moderna pediatric dose instead of the bivalent booster dose.).    Concomitant medications were not reported. No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-697687 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-697687 case
pt recv 2 doses of vax 19JAN96 & 23FEB96 & 23AUG96 lab eval revealed a negative titer;
Times are approximates.  Patient reports to have started experiencing an increase in symptoms of paranoia and thought disorganization in the days immediately following her first injection of the Pfizer COVID19 vaccine.   Patient was medically evaluated by myself via teleHEALTH 16 days later and found to be increasingly paranoid, with somatic preoccupations, increased thought and speech disorganization  that may require additional antipsychotic medication.  This mental status examination represents a significant worsening compared to the patient's baseline.